Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas Gad currently holds 143,169 shares of Y-mAbs Therapeutics, Inc. (YMAB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Gad has been a net seller of YMAB stock. They have purchased $0 and sold $47.4M worth of shares.
Thomas Gad's most recent insider trade was on Sep 16, 2025, when they sold 67,681 shares at $8.60 per share.
Thomas Gad serves as Executive at Y-mAbs Therapeutics, Inc. (YMAB). They have executed 158 insider transactions totaling $47.4M over their tenure at the company.
Thomas Gad holds the position of Executive at Y-mAbs Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Thomas Gad has shown a selling trading pattern, with $0 in total purchases and $47.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Thomas Gad was on Sep 16, 2025, when they sold $2.1M worth of YMAB shares. This transaction involved 245,486 shares at $8.60 per share.
Thomas Gad currently owns 143,169 shares of Y-mAbs Therapeutics, Inc. (YMAB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas Gad's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas Gad has 158 Form 4 filings on record as an insider at Y-mAbs Therapeutics, Inc..
Set alerts for Thomas Gad and 40,000+ other insiders.